Proteomic temporal profile of human brain endothelium after oxidative stress

Stroke

Volumn 42, Issue 1, 2011, Pages 37-43

  Ning, Mingming ^a   Sarracino, David A ^c   Kho, Alvin T ^a,b   Guo, Shuzhen ^a   Lee, Sun Ryung ^a   Krastins, Bryan ^c   Buonanno, Ferdinando S ^a   Vizcaíno, Juan A ^d   Orchard, Sandra ^d   McMullin, David ^a   Wang, Xiaoying ^a   Lo, Eng H ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c LABORATORY FOR MOLECULAR MEDICINE   (United States)

^d EUROPEAN BIOINFORMATICS INSTITUTE   (United Kingdom)

Author keywords

Biomarker; Cerebral ischemia; Human brain endothelial cells; Oxidative stress; Proteomics

Indexed keywords

ACTIN; CXCL1 CHEMOKINE; DESMOGLEIN; ENOLASE; ENOLASE 1; ENTACTIN; FIBRONECTIN; FIBRONECTIN 1; FILAMIN; FILAMIN B; HEAT SHOCK PROTEIN; INTERLEUKIN 6; INTERLEUKIN 8; LIPOCORTIN 5; NEUROTROPHIC FACTOR; NITROPRUSSIDE SODIUM; NUCLEOBINDIN 1; PROFILIN; PROFILIN I; PROSAPOSIN; PROTACHYKININ; PROTEIN PRECURSOR; SERUM AMYLOID A; SERUM AMYLOID A1; TAU PROTEIN; THROMBOSPONDIN 1; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TRANSFORMING GROWTH FACTOR BETA2; UNCLASSIFIED DRUG; VIMENTIN;

ARTICLE; BASEMENT MEMBRANE; BRAIN CELL; BRAIN ENDOTHELIAL CELL; BRAIN ISCHEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENDOTHELIUM INJURY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; MALE; MOLECULAR INTERACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEOMICS; QUANTITATIVE ANALYSIS; RISK FACTOR; SCREENING; SINGLE NUCLEOTIDE POLYMORPHISM; TISSUE REPAIR;

BIOLOGICAL MARKERS; BRAIN; CELL LINE; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; FEMALE; FREE RADICAL SCAVENGERS; HUMANS; INFLAMMATION MEDIATORS; MALE; NITRIC OXIDE; OXIDATIVE STRESS; PROTEOME; STROKE; TIME FACTORS;

EID: 79451475234     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.110.585703     Document Type: Article

References (26)

1. Iadecola C. Neurovascular regulation in the normal brain and in Alzheimer's disease. Nat Rev Neurosci. 2004;5:347-360.
2. Hawkins BT, Davis TP. The blood-brain barrier/neurovascular unit in health and disease. Pharmacol Rev. 2005;57:173-185.
3. Zlokovic BV. The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron. 2008;57:178-201.
4. Zacchigna S, Lambrechts D, Carmeliet P. Neurovascular signalling defects in neurodegeneration. Nat Rev Neurosci. 2008;9:169-181.
5. Foerch C, Montaner J, Furie KL, Ning MM, Lo EH. Invited article: searching for oracles? Blood biomarkers in acute stroke. Neurology. 2009;73:393-399.
6. Guo S, Kim WJ, Lok J, Lee SR, Besancon E, Luo BH, Stins MF, Wang X, Dedhar S, Lo EH. Neuroprotection via matrix-trophic coupling between cerebral endothelial cells and neurons. Proc Natl Acad Sci U S A. 2008;105:7582-7587.
7. López-Otin C, Overall CM. Protease degradomics: a new challenge for proteomics. Nat Rev Mol Cell Biol. 2002;3:509-519.
8. Liotta LA, Ferrari M, Petricoin E. Clinical proteomics: Written in blood. Nature. 2003;425:905
9. Eyk JE, Dunn MJ (eds). Clinical proteomics. Weinheim, Germany: Wiley-VCH; 2008.
10. Mulder NJ, Apweiler R, Attwood TK, Bairoch A, Bateman A, Binns D, Bork P, Buillard V, Cerutti L, Copley R, Courcelle E, Das U, Daugherty L, Dibley M, Finn R, Fleischmann W, Gough J, Haft D, Hulo N, Hunter S, Kahn D, Kanapin A, Kejariwal A, Labarga A, Langendijk-Genevaux PS, Lonsdale D, Lopez R, Letunic I, Madera M, Maslen J, McAnulla C, McDowall J, Mistry J, Mitchell A, Nikolskaya AN, Orchard S, Orengo C, Petryszak R, Selengut JD, Sigrist CJ, Thomas PD, Valentin F, Wilson D, Wu CH, Yeats C. New developments in the InterPro database. Nucleic Acids Res. 2007;35:D224-228.
11. Rhodes DR, Tomlins SA, Varambally S, Mahavisno V, Barrette T, Kalyana-Sundaram S, Ghosh D, Pandey A, Chinnaiyan AM. Probabilistic model of the human protein-protein interaction network. Nat Biotechnol. 2005;23:951-959.
12. Lawler J, Detmar M. Tumor progression: the effects of thrombospondin-1 and-2. Int J Biochem Cell Biol 2004 36 1038-1045.
13. Rusnati M, Presta M. Extracellular angiogenic growth factor interactions: an angiogenesis interactome survey. Endothelium. 2006;13:93-111.
14. Jauch E, Dean C, Carrozzella J, Smulian AG, Wagner KR. Proteomic analyses demonstrates ultra-early elevations of inflammation-sensitive plasma proteins following ischemic stroke. 5th World Stroke Congress, Vancouver BC, Canada. June 23-26, 2004.
15. Arai K, Lo EH. An oligovascular niche: cerebral endothelial cells promote the survival and proliferation of oligodendrocyte precursor cells. J Neurosci. 2009;29:4351-4355.
16. Pottiez G, Sevin E, Cecchelli R, Karamanos Y, Flahaut C. Actin, gelsolin and filamin-A are dynamic actors in the cytoskeleton remodelling contributing to the blood brain barrier phenotype. Proteomics. 2009;9:1207-1219.
17. Haqqani AS, Kelly J, Baumann E, Haseloff RF, Blasig IE, Stanimirovic DB. Protein markers of ischemic insult in brain endothelial cells identified using 2D gel electrophoresis and ICAT-based quantitative proteomics. J Proteome Res. 2007;6:226-239.
18. Anderson NL, Anderson NG. The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics. 2002;1: 845-867.
19. Ping P, Vondriska TM, Creighton CJ, Gandhi TK, Yang Z, Menon R, Kwon MS, Cho SY, Drwal G, Kellmann M, Peri S, Suresh S, Gronborg M, Molina H, Chaerkady R, Rekha B, Shet AS, Gerszten RE, Wu H, Raftery M, Wasinger V, Schulz-Knappe P, Hanash SM, Paik YK, Hancock WS, States DJ, Omenn GS, Pandey A. A functional annotation of subproteomes in human plasma. Proteomics. 2005;5:3506-3519.
20. Hayashi T, Noshita N, Sugawara T, Chan PH. Temporal profile of angiogenesis and expression of related genes in the brain after ischemia. J Cereb Blood Flow Metab. 2003;23:166-180.
21. Castellanos M, Leira R, Serena J, Blanco M, Pedraza S, Castillo J, Dávalos A. Plasma cellular-fibronectin concentration predicts hemorrhagic transformation after thrombolytic therapy in acute ischemic stroke. Stroke. 2004;35:1671-1676.
22. Alvarez-Sabín J, Delgado P, Abilleira S, Molina CA, Arenillas J, Ribó M, Santamarina E, Quintana M, Monasterio J, Montaner J. Temporal profile of matrix metalloproteinases and their inhibitors after spontaneous intracerebral hemorrhage: relationship to clinical and radiological outcome. Stroke. 2004;35:1316-1322.
23. Vila N, Castillo J, Dávalos A, Chamorro A. Proinflammatory cytokines and early neurological worsening in ischemic stroke. Stroke. 2000;31: 2325-2329.
24. Lu Q, Murugesan N, Macdonald JA, Wu SL, Pachter JS, Hancock WS. Analysis of mouse brain microvascular endothelium using immuno-laser capture microdissection coupled to a hybrid linear ion trap with Fourier transform-mass spectrometry proteomics platform. Electrophoresis. 2008;29:2689-2695.
25. Chan PH. Reactive oxygen radicals in signaling and damage in the ischemic brain. J Cereb Blood Flow Metab. 2001;21:2-14.
26. Haqqani AS, Kelly JF, Stanimirovic DB. Quantitative protein profiling by mass spectrometry using label-free proteomics. Methods Mol Biol. 2008; 439:241-256.